Back to funds
View filing
Eversept Partners, LP
hedge fundUpdated 27 days agoManaged by Eversept Partners, Lp • Latest filing Q2 2026
Portfolio value
$1.9B
Q2 2026
Filings
13
Quarterly 13F history
Top-10 concentration
95.2%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 21 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2017 | $173.8M |
| Q1 2018 | $215.3M |
| Q3 2020 | $636K |
| Q1 2022 | $1.3B |
| Q2 2022 | $1.4B |
| Q3 2022 | $1.2B |
| Q4 2022 | $1.1B |
| Q1 2023 | $1.4B |
| Q2 2023 | $1.2B |
| Q3 2023 | $1.2B |
| Q4 2023 | $1.1B |
| Q1 2024 | $1.5B |
| Q2 2024 | $1.5B |
| Q3 2024 | $1.5B |
| Q4 2024 | $1.1B |
| Q1 2025 | $984.7M |
| Q2 2025 | $1.1B |
| Q3 2025 | $1.5B |
| Q4 2025 | $2B |
| Q1 2026 | $1.9B |
| Q2 2026 | $1.9B |
Top holdings
120 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | U UTHR UNITED THERAPEUTICS CORP DEL | $155.9M | 287.7K | 8.09% | — |
| 2 | A AAVXF ABIVAX SA | $121.8M | 913.9K | 6.32% | — |
| 3 | E EHC ENCOMPASS HEALTH CORP | $103.8M | 1.03M | 5.38% | — |
| 4 | E ENSG ENSIGN GROUP INC | $96.5M | 602.1K | 5.01% | — |
| 5 | V VERA VERA THERAPEUTICS INC | $94.9M | 2.21M | 4.93% | — |
| 6 | Q QQQ INVESCO QQQ TR | $72.6M | 98.6K | 3.77% | — |
| 7 | C CLDX CELLDEX THERAPEUTICS INC NEW | $66.5M | 1.79M | 3.45% | — |
| 8 | S SNDX SYNDAX PHARMACEUTICALS INC | $61.2M | 2.80M | 3.17% | — |
| 9 | B BKD BROOKDALE SR LIVING INC | $54.6M | 3.40M | 2.83% | — |
| 10 | I IONS IONIS PHARMACEUTICALS INC | $52.7M | 664.7K | 2.73% | — |
| 11 | N NTRA NATERA INC | $47.7M | 175.8K | 2.48% | — |
| 12 | T TVTX TRAVERE THERAPEUTICS INC | $45.4M | 799.0K | 2.35% | — |
| 13 | C CTRE CARETRUST REIT INC | $43.3M | 1.07M | 2.24% | — |
| 14 | H HCA HCA HEALTHCARE INC | $38.3M | 98.3K | 1.99% | — |
| 15 | P PCVX VAXCYTE INC | $36.6M | 630.0K | 1.90% | — |
| 16 | L LQDA LIQUIDIA CORPORATION | $34.2M | 428.7K | 1.77% | — |
| 17 | C CYH COMMUNITY HEALTH SYS INC NEW | $26.3M | 7.86M | 1.36% | — |
| 18 | G GLAXF GSK PLC | $25.3M | 481.8K | 1.31% | — |
| 19 | C CHE CHEMED CORP NEW | $24.5M | 52.5K | 1.27% | — |
| 20 | L LLY ELI LILLY & CO | $24.1M | 20.1K | 1.25% | — |